The current status of FDG-PET in tumour volume definition in radiotherapy treatment planning.
about
Validation of functional imaging as a biomarker for radiation treatment responseInsight on automated lesion delineation methods for PET data.Application of machine learning methodology for PET-based definition of lung cancer.Adaptive region-growing with maximum curvature strategy for tumor segmentation in 18F-FDG PET.Broadening the scope of image-guided radiotherapy (IGRT).Predictive value of metabolic 18FDG-PET response on outcomes in patients with locally advanced pancreatic carcinoma treated with definitive concurrent chemoradiotherapy.The effect of tumor volume and its change on survival in stage III non-small cell lung cancer treated with definitive concurrent chemoradiotherapyPET-CT guided curative conformal radiation therapy in limited stage small cell lung cancerImaging of lung cancer: Implications on staging and management.An evaluation of the variability of tumor-shape definition derived by experienced observers from CT images of supraglottic carcinomas (ACRIN protocol 6658).Early CT and FDG-metabolic tumour volume changes show a significant correlation with survival in stage I-III small cell lung cancer: a hypothesis generating study.Epithelial and mesenchymal tumor compartments exhibit in vivo complementary patterns of vascular perfusion and glucose metabolism.PET/CT-guided treatment planning for paediatric cancer patients: a simulation study of proton and conventional photon therapy.Positron emission tomography imaging approaches for external beam radiation therapies: current status and future developmentsTargeted molecular imaging in oncology: focus on radiation therapy.Estimate of the impact of FDG-avidity on the dose required for head and neck radiotherapy local controlMulti-modality nuclear medicine imaging: artefacts, pitfalls and recommendations.The impact of functional imaging on radiation medicineFDG-PET/CT imaging for staging and radiotherapy treatment planning of head and neck carcinoma.Comparison of CT and PET-CT based planning of radiation therapy in locally advanced pancreatic carcinomaThe role of PET in target localization for radiotherapy treatment planning.PET/CT in the management of haematological malignancies.Anniversary paper: Role of medical physicists and the AAPM in improving geometric aspects of treatment accuracy and precision.Radical chemoradiotherapy for adenocarcinoma of the distal oesophagus and oesophagogastric junction: what planning margins should we use?PET/CT for staging and monitoring non small cell lung cancerComparison of CT and integrated PET-CT based radiation therapy planning in patients with malignant pleural mesothelioma.FDG-PET/CT imaging for tumor staging and definition of tumor volumes in radiation treatment planning in non-small cell lung cancer.PET and PET-CT in radiation treatment planning for lung cancer.Strategies of assessing and quantifying radiation treatment metabolic tumor response using F18 FDG Positron Emission Tomography (PET).PET imaging in lymphoma.Integrated FDG PET/CT: Utility and Applications in Clinical Oncology.Modelling tumour volume variations in head and neck cancer: contribution of magnetic resonance imaging for patients undergoing induction chemotherapy.Evaluation of the spatial dependence of the point spread function in 2D PET image reconstruction using LOR-OSEM.Evaluation of the Metabolic Response to Cyclopamine Therapy in Pancreatic Cancer Xenografts Using a Clinical PET-CT SystemCine computed tomography without respiratory surrogate in planning stereotactic radiotherapy for non-small-cell lung cancer.A partial volume effect correction tailored for 18F-FDG-PET oncological studies.RT_Image: an open-source tool for investigating PET in radiation oncology.Target definition of moving lung tumors in positron emission tomography: correlation of optimal activity concentration thresholds with object size, motion extent, and source-to-background ratio.Lesion quantification in oncological positron emission tomography: a maximum likelihood partial volume correction strategy.A novel fuzzy C-means algorithm for unsupervised heterogeneous tumor quantification in PET.
P2860
Q26823165-EF3233E3-0F5C-4F61-B4DF-0EADF57D8E5EQ30884650-2765CD1E-0418-46BF-BE27-639062590A1AQ33680357-37DA4740-DAE7-43FE-B0E9-E0170D4C5921Q33873255-EEE85A1C-2AF6-48C8-AA1A-C0E7436E0176Q33943514-506CA425-B292-49AD-912D-6EAD4C1A3052Q34072096-0F94D6A8-4E86-447B-B0A0-62A4D1C20FD0Q34720945-9296EEA3-0CE4-4B6A-8B0C-5E8BE3A69B7CQ35290430-97176E08-EC7C-409B-AC5C-6E26D7C1EEF7Q35568718-FCC6897B-20F5-42C7-8BD6-DD253AB4A1BAQ35842998-CCDE7154-B781-4C47-A7B8-E2E41727E243Q36014679-A46F635D-5D7E-4EEC-A637-B1995ECB5CA9Q36143593-732C5499-88A3-42F1-9639-591A6E848B57Q36295229-02686BD4-7DDD-416A-932E-AD7A751D3F7BQ36325435-ACD52CF4-F3EA-476D-BA97-E14F076E9945Q36528175-358AA452-EDDD-44A2-9A3A-74D9EA39FAF8Q36770099-675885A8-4332-4487-8B23-AC2F1BCEF0E5Q36834532-115DF025-D3F1-414A-8D2D-03A2C352DD06Q36908974-F694CE54-BDF7-45C9-93B6-12B2BB04BF65Q36919818-3FFA521D-ECE5-484A-B3D5-F84D73F189DDQ36924872-A4FCC0D8-A22D-4103-BA4B-29D820A308E1Q37082395-2170E4B9-FF42-4CE8-83D1-F0726A561EC4Q37088536-31B21A45-6B66-4B7C-9B5A-6D46D66E77FAQ37135670-30B5EA46-FE3C-42D9-950F-CE2C330884FBQ37270111-05B47319-6766-459F-BC3D-1564830B29B8Q37292826-03CB0C11-130E-4A6F-821F-8FD645D9C408Q37368672-9A4359B7-531D-4848-8154-7894A8826A38Q37652687-ECCBB108-EAFB-4083-A6C1-65506AB76B9BQ37732292-A55CDACB-599A-4093-B0F3-FDAF50397A86Q37787276-74129036-C6FD-44CF-9840-18C2772BC40DQ37810092-F6672F7E-0178-4E11-8EC9-B4900879C863Q38260852-3861D812-0C3D-4ECC-BFE0-715A4A9DC0A2Q39145943-D8D387D0-261E-4E14-960C-D85D038CDD0AQ39597606-03976E61-F681-4337-846B-DCCE76341D1DQ41763471-5EF8DD04-A73A-47B4-B6A9-E2040CDA0FF7Q41967419-AD260918-25DE-40DB-B88A-2850EFF5A4BCQ42255415-ADAAF290-9EFF-4505-9876-6505DFDE8C41Q42615272-5EC0086D-B3D0-41EA-82B7-6B1C5A9C3135Q42918013-B39ACE11-31CD-47F1-9D96-5E9676D1215DQ43293429-C7200555-E8D7-43F0-9662-9E955CBE2460Q45071235-EEE28785-AD80-48D8-A929-D1E4E22C1DD0
P2860
The current status of FDG-PET in tumour volume definition in radiotherapy treatment planning.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
The current status of FDG-PET ...... diotherapy treatment planning.
@ast
The current status of FDG-PET ...... diotherapy treatment planning.
@en
type
label
The current status of FDG-PET ...... diotherapy treatment planning.
@ast
The current status of FDG-PET ...... diotherapy treatment planning.
@en
prefLabel
The current status of FDG-PET ...... diotherapy treatment planning.
@ast
The current status of FDG-PET ...... diotherapy treatment planning.
@en
P2093
P50
P1476
The current status of FDG-PET ...... diotherapy treatment planning.
@en
P2093
Brigitta G Baumert
Geert Bosmans
Marinus van Kroonenburgh
Philippe Lambin
Vincent Gregoire
P304
P356
10.1016/J.CTRV.2006.02.002
P577
2006-03-24T00:00:00Z